GLP-1 Multi-District Litigation | Updates And What You Need To Know

The wave of lawsuits involving GLP-1 receptor agonists—such as Ozempic, Wegovy, Trulicity, and Mounjaro—has evolved into one of the most closely watched mass torts in the country. These medications, primarily prescribed for type 2 diabetes and weight loss, are now at the center of thousands of claims alleging severe gastrointestinal injuries. As of mid-2025, the MDL (Multidistrict Litigation) No. 3094 in the Eastern District of Pennsylvania has grown to include over 1,800 active cases, with plaintiffs continuing to join weekly.

At Sneed & Mitchell LLP, we are actively representing clients who suffered gastroparesis, intestinal blockage, and related conditions after taking GLP-1 medications. This article explains the current status of the MDL, key legal developments, medical findings, and what claimants can do to strengthen their lawsuits.

What Is MDL 3094?

MDL 3094 consolidates federal lawsuits against Novo Nordisk (maker of Ozempic, Rybelsus, Wegovy) and Eli Lilly (maker of Trulicity and Mounjaro). Plaintiffs allege these companies failed to adequately warn about the risk of severe and sometimes permanent gastrointestinal complications.

The cases are being heard before Judge Gene E.K. Pratter (Note: Judge assignments may change), with centralized discovery and pretrial proceedings taking place to streamline evidence gathering and rulings.

The Primary Allegations

Plaintiffs in the GLP-1 MDL allege:

• Failure to warn consumers and doctors about the risks of gastroparesis and intestinal obstruction

• Design defects in the medications

• Inadequate post-market surveillance and reaction to adverse events

• Negligent marketing practices that downplayed serious side effects

These claims are supported by growing adverse event reports and emerging studies linking GLP-1 medications to prolonged and debilitating digestive disorders.

Injuries Linked to GLP-1 Drugs

1. Gastroparesis (Delayed Gastric Emptying): A condition where food remains in the stomach longer than normal. Symptoms include chronic nausea, vomiting, bloating, and malnutrition. In many lawsuits, patients were hospitalized and required feeding tubes or surgical intervention.

2. Intestinal Obstruction and Ileus: Patients experienced severe blockages in the intestines, often requiring emergency care or surgery. These conditions can lead to sepsis and permanent digestive impairment.

3. Severe Vomiting and GI Inflammation: Prolonged use of GLP-1 medications has reportedly caused uncontrolled vomiting and inflammation, disrupting patients' ability to work and live normal lives.

Some lawsuits also allege additional injuries like pancreatitis, vision loss, or gallbladder disease, though these are not currently the focus of MDL 3094.

Legal Developments and the 2025 Roadmap

Rule 702 Hearing Scheduled (May 14, 2025): This hearing will determine the admissibility of expert witness testimony regarding causation. Plaintiffs must prove that GLP-1 drugs can cause gastroparesis and similar conditions. This is a pivotal step that may define the fate of many claims.

Case Filings and Growth: Over 1,800 lawsuits are currently centralized. With continued advertising and public awareness, this number could surpass 3,000 before 2026.

Bellwether Trial Selection: In late 2025, the court is expected to select several "bellwether" cases to proceed to early trial. These outcomes will help shape global settlement talks.

Medical Evidence and Label Warnings

Initially, product labels did not explicitly mention gastroparesis. Following litigation pressure, some manufacturers updated labels to include vague references to "delayed gastric emptying" and intestinal risks. Plaintiffs argue these changes came far too late.

The FDA has not yet mandated black-box warnings. However, litigation has unearthed internal emails and studies allegedly showing the manufacturers were aware of these risks long before public disclosure.

Strategy: Building a Strong Claim

At Sneed & Mitchell LLP, we help clients preserve and develop their cases by:

• Gathering comprehensive medical evidence (diagnosis, imaging, ER records)

• Documenting symptoms through journals and witness statements

• Issuing evidence preservation letters to pharmacies and prescribers

• Preparing pre-litigation demand packages to support early resolution

• Retaining medical experts to provide causation opinions

Every case is prepared as if it will go to trial. We believe this level of preparation maximizes your chance at receiving a full and fair settlement.

The Damages Available To Victims

GLP-1 plaintiffs may be entitled to recover for:

• Medical bills (past and future)

• Lost wages and diminished earning capacity

• Pain and suffering

• Loss of enjoyment of life

• Permanent disability

• Emotional distress

• In cases of egregious conduct, punitive damages

We take time to understand each client’s story, ensuring your claim fully reflects the ways this drug has changed your life.

Frequently Asked Questions Regarding The GLP-1 Mass Tort Case

Q: How do I know if I have a claim?If you took Ozempic, Wegovy, Mounjaro, or similar drugs and developed persistent vomiting, gastroparesis, or intestinal issues requiring medical care, you likely qualify. Contact us for a free case evaluation.

Q: Is there a deadline to file?Yes. Each state has statutes of limitations that limit how long you have to file a civil lawsuit. Delays can jeopardize your ability to recover.

Q: Will I need to testify?Most plaintiffs will not testify unless their case goes to trial. If selected for a bellwether, we prepare you thoroughly.

Q: Can I join if I’ve already received some compensation?Possibly. You may still pursue additional recovery. We review each case for overlapping insurance or settlement issues.

Why Choose Sneed & Mitchell LLP?

• Undefeated in trial and complex product liability litigation

• National reach with a personal, boutique-level focus

• Contingency fee structure: no payment unless we win

• Over 50 years of compained eperience holding multi-national companies accountable

We don’t just build cases, we build leverage. Our firm fights to obtain full compensation, not just quick settlements. If you or a loved one would like to speak with an attorney regarding the injuries you sustained while on a GLP-1 medication, give us a call at 866-434-0014 today.